Wave Life Sciences to Webcast Conference Call of Third Quarter 2021 Financial Results on November 10, 2021

Rhea-AI Summary

Wave Life Sciences Ltd. (Nasdaq: WVE) announced a live webcast and conference call for its third quarter 2021 financial results, scheduled for November 10, 2021, at 8:30 a.m. ET. The event will provide important business updates and can be accessed via the company's Investor Relations website or by phone with the provided dial-in details. Wave Life Sciences is focused on developing genetic medicines through its proprietary PRISM platform, aiming to deliver innovative therapies for genetically defined diseases.

Positive

• Upcoming conference call to discuss third quarter 2021 financial results and business updates.

Negative

• None.

CAMBRIDGE, Mass., Nov. 01, 2021 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced today that management will host a live webcast and conference call at 8:30 a.m. ET on Wednesday, November 10, 2021, to discuss its third quarter 2021 financial results and provide a business update.

The webcast of the conference call may be accessed by visiting the “Events” section in the Investor Relations page of the Wave Life Sciences website at www.wavelifesciences.com. The live teleconference may be accessed by dialing (866) 220-8068 (domestic) or (470) 495-9153 (international) and entering conference ID: 6995569. Following the conference call, an archived version of the call will be available on the website. 

About Wave Life Sciences
Wave Life Sciences (Nasdaq: WVE) is a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases. Wave aspires to develop best-in-class medicines across multiple therapeutic modalities using PRISM, the company’s proprietary discovery and drug development platform that enables the precise design, optimization, and production of stereopure oligonucleotides. Driven by a resolute sense of urgency, the Wave team is targeting a broad range of genetically defined diseases so that patients and families may realize a brighter future. To find out more, please visit www.wavelifesciences.com and follow Wave on Twitter @WaveLifeSci.

Investor Contact:
Kate Rausch
617-949-4827
krausch@wavelifesci.com

Media Contact:
Alicia Suter
617-949-4817
asuter@wavelifesci.com

FAQ

When will Wave Life Sciences announce its third quarter 2021 financial results?

Wave Life Sciences will announce its third quarter 2021 financial results on November 10, 2021, at 8:30 a.m. ET.

How can I access the Wave Life Sciences conference call?

The conference call can be accessed via the Events section on the Wave Life Sciences Investor Relations website or by calling (866) 220-8068 for domestic and (470) 495-9153 for international participants.

What is the purpose of the Wave Life Sciences live webcast?

The live webcast will discuss the third quarter 2021 financial results and provide a business update.

What is the ticker symbol for Wave Life Sciences?

The ticker symbol for Wave Life Sciences is WVE.